The activities of amyloids from a structural perspective.
about
Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates.Quenched hydrogen-deuterium exchange NMR of a disease-relevant Aβ(1-42) amyloid polymorphZinc-binding structure of a catalytic amyloid from solid-state NMR.Outlining Core Pathways of Amyloid Toxicity in Bacteria with the RepA-WH1 Prionoid.Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology.Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspectiveProduction of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.Cryo-EM structures of tau filaments from Alzheimer's disease.Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease.Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy.Conformational Ensembles of the Wild-Type and S8C Aβ1-42 Dimers.Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.Factors affecting the physical stability (aggregation) of peptide therapeutics.Inhibiting the Ca2+ Influx Induced by Human CSF.A specific form of prefibrillar aggregates that functions as a precursor of amyloid nucleation.Energetics Underlying Twist Polymorphisms in Amyloid Fibrils.Recent progress on understanding the mechanisms of amyloid nucleation.Formation and properties of amyloid fibrils of prion protein.Combining in vitro and in silico approaches to find new drugs targeting the pathological proteins related to the Alzheimer's disease.Propagation of Fibrillar Structural Forms in Proteins Stopped by Naturally Occurring Short Polypeptide Chain Fragments.Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.The molecular basis of Alzheimer's plaques.Amyloidogenesis of Tau protein.Amyloid fibril polymorphism - a challenge for molecular imaging and therapy.Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.Sequence dependent aggregation of peptides and fibril formation.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Fibril structure of amyloid-β(1-42) by cryo-electron microscopy.Vaccination strategies in tauopathies and synucleinopathies.Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer's Disease.Controlled Exposure of Bioactive Growth Factor in 3D Amyloid Hydrogel for Stem Cells Differentiation.'Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum.Exceptional in vivo catabolism of neurodegeneration-related aggregates.VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.Distal Amyloid β-Protein Fragments Template Amyloid Assembly.Small static electric field strength promotes aggregation-prone structures in amyloid-β(29-42).
P2860
Q34556269-D92C842A-96BD-42B4-896C-56849C3636B9Q36314605-8E51C429-EC7B-4AA3-A7EB-806950F62ED9Q36388060-88D8D17D-2EBF-4FE5-A079-131185A6B23BQ37736093-D8C85213-004A-42FB-BBCF-9EA15B3C8E73Q39322110-0D6DB351-B13D-4CB2-AE50-2035B36F6F10Q39384630-8DF517E4-C571-4BE2-B287-0C36BD475B02Q39445835-A78EB307-95EC-4E8B-98E8-595CAB541D40Q41044393-BA3A54DE-0128-4188-8C6E-ED0B730AA9E0Q41548991-A385EA5E-E413-41ED-8F41-24331F11333BQ41597304-CC3E529E-7533-480E-A3CF-F0849741A1FCQ42367176-EA780E48-CD17-4EB2-8AEC-DBE93CFE2CE3Q42367749-21254AEB-57CF-4444-823C-D37793E81C6DQ44870524-709377ED-D504-437C-92BE-AEC1FAD74BF1Q45327210-13D3D1EC-75BA-40D3-A92C-46505B3C820FQ46259884-71276FD3-312A-4C6C-BAE0-10EDAD4E5492Q47144784-A88071D2-5E53-47D4-A694-239D34A0DFD7Q47222549-B3AF6140-9B05-4626-9012-3BF0992D40A9Q47279865-7B752DC6-A5F1-4028-A982-419EC1AB5ABEQ47321010-59AF6BBF-85D0-465D-812A-8CA837BF765DQ47330886-5F590F90-8F49-4DFF-B182-5BAD7AC3DAADQ47396500-F5BDE82D-055C-49B9-97EE-12A872C3F009Q47396577-C588ADC1-10D3-4442-BEC2-E89F9C6330B3Q47404960-D5450838-E40E-46B5-8D0C-2FA5EA13F1ABQ47689801-B175CEDD-0A3D-4608-A4CE-23719DBBBF89Q47715943-A6B8C025-62DF-437A-ABEC-FEECA8DE90ADQ47717455-2E9E955D-8291-4BFD-A0D4-B9BBE7E80687Q47722422-FF01FF23-023F-4BBE-8CE8-1DD0869B9E93Q47727255-22ECDD5C-8DCF-4E65-AED7-7433B22C03A3Q47759823-D6A1D5BA-BBAE-457B-9C34-D28C73BF686DQ47795042-092FE2A5-717B-4A2E-A2D1-BA23B02D7DDBQ47833979-E8D1BB05-9274-4970-A59C-7587A561B8B5Q47838176-0BB0A3A6-4DFD-4CD3-9B91-D562E4C8AEB2Q47860105-EF3DC3F5-C5AC-483D-8280-A36A3CE11504Q47865422-F30A53BB-49B1-44ED-A7FC-2E9CCC2E8B5FQ47889447-EF2F1E78-3E9F-41EE-8382-B8F32D3DE5BCQ47995205-A0E81525-0E2E-4D00-8C58-38E77EDB7515Q48043354-663D2B56-6B81-49E2-923F-0E1C6A3D5B77Q48093443-BFE4C8AB-8FCF-45D5-BBF0-98C097D5F635Q48211250-3EA334D6-FFD1-4F36-94F7-1957E1073375Q48272732-C7890ABA-9500-4A04-B331-8C7128A6F540
P2860
The activities of amyloids from a structural perspective.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The activities of amyloids from a structural perspective.
@en
The activities of amyloids from a structural perspective.
@nl
type
label
The activities of amyloids from a structural perspective.
@en
The activities of amyloids from a structural perspective.
@nl
prefLabel
The activities of amyloids from a structural perspective.
@en
The activities of amyloids from a structural perspective.
@nl
P2860
P356
P1433
P1476
The activities of amyloids from a structural perspective.
@en
P2093
David S Eisenberg
Roland Riek
P2860
P2888
P304
P356
10.1038/NATURE20416
P407
P577
2016-11-09T00:00:00Z